ResMed Return on Tangible Equity 2010-2025 | RMD
Current and historical return on tangible equity values for ResMed (RMD) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| ResMed Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $1.31B | $2.27B | 68.72% |
| 2024-12-31 | $1.25B | $2.01B | 74.85% |
| 2024-09-30 | $1.11B | $1.83B | 77.34% |
| 2024-06-30 | $1.02B | $1.54B | 85.07% |
| 2024-03-31 | $0.96B | $1.29B | 94.22% |
| 2023-12-31 | $0.89B | $1.09B | 106.29% |
| 2023-09-30 | $0.91B | $0.88B | 137.16% |
| 2023-06-30 | $0.90B | $0.81B | 122.76% |
| 2023-03-31 | $0.86B | $0.58B | 107.98% |
| 2022-12-31 | $0.81B | $0.38B | 90.01% |
| 2022-09-30 | $0.79B | $1.16B | 77.96% |
| 2022-06-30 | $0.78B | $1.08B | 86.52% |
| 2022-03-31 | $0.78B | $0.98B | 100.87% |
| 2021-12-31 | $0.52B | $0.82B | 84.02% |
| 2021-09-30 | $0.50B | $0.73B | 90.72% |
| 2021-06-30 | $0.48B | $0.57B | 104.05% |
| 2021-03-31 | $0.46B | $0.37B | 129.01% |
| 2020-12-31 | $0.70B | $0.54B | 293.39% |
| 2020-09-30 | $0.68B | $0.35B | 852.66% |
| 2020-06-30 | $0.62B | $0.16B | -946.01% |
| 2020-03-31 | $0.51B | $-0.09B | -281.87% |
| 2019-12-31 | $0.46B | $-0.09B | -170.25% |
| 2019-09-30 | $0.42B | $-0.24B | -132.59% |
| 2019-06-30 | $0.41B | $-0.31B | -288.26% |
| 2019-03-31 | $0.45B | $-0.43B | 343.74% |
| 2018-12-31 | $0.45B | $-0.29B | 105.44% |
| 2018-09-30 | $0.34B | $0.47B | 49.72% |
| 2018-06-30 | $0.32B | $0.78B | 42.66% |
| 2018-03-31 | $0.31B | $0.76B | 43.66% |
| 2017-12-31 | $0.29B | $0.70B | 43.98% |
| 2017-09-30 | $0.35B | $0.73B | 61.79% |
| 2017-06-30 | $0.34B | $0.63B | 69.33% |
| 2017-03-31 | $0.32B | $0.54B | 77.10% |
| 2016-12-31 | $0.33B | $0.39B | 58.26% |
| 2016-09-30 | $0.35B | $0.42B | 47.48% |
| 2016-06-30 | $0.35B | $0.34B | 38.68% |
| 2016-03-31 | $0.36B | $1.10B | 31.11% |
| 2015-12-31 | $0.36B | $1.06B | 30.24% |
| 2015-09-30 | $0.35B | $1.16B | 28.55% |
| 2015-06-30 | $0.35B | $1.28B | 27.58% |
| 2015-03-31 | $0.35B | $1.23B | 26.87% |
| 2014-12-31 | $0.35B | $1.27B | 26.20% |
| 2014-09-30 | $0.35B | $1.33B | 25.73% |
| 2014-06-30 | $0.35B | $1.42B | 25.44% |
| 2014-03-31 | $0.33B | $1.35B | 24.97% |
| 2013-12-31 | $0.33B | $1.30B | 24.20% |
| 2013-09-30 | $0.32B | $1.36B | 23.05% |
| 2013-06-30 | $0.31B | $1.29B | 22.30% |
| 2013-03-31 | $0.31B | $1.44B | 22.55% |
| 2012-12-31 | $0.29B | $1.41B | 21.72% |
| 2012-09-30 | $0.28B | $1.37B | 21.30% |
| 2012-06-30 | $0.26B | $1.30B | 20.34% |
| 2012-03-31 | $0.24B | $1.28B | 18.29% |
| 2011-12-31 | $0.23B | $1.24B | 17.03% |
| 2011-09-30 | $0.22B | $1.22B | 16.33% |
| 2011-06-30 | $0.23B | $1.45B | 16.82% |
| 2011-03-31 | $0.22B | $1.38B | 17.73% |
| 2010-12-31 | $0.22B | $1.34B | 18.53% |
| 2010-09-30 | $0.21B | $1.21B | 18.91% |
| 2010-06-30 | $0.19B | $1.06B | 18.64% |
| 2010-03-31 | $0.18B | $1.08B | 18.73% |
| 2009-12-31 | $0.17B | $0.99B | 19.42% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $36.560B | $4.685B |
| ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $235.957B | 28.04 |
| Boston Scientific (BSX) | United States | $147.560B | 37.59 |
| Stryker (SYK) | United States | $144.011B | 30.10 |
| EssilorLuxottica (ESLOY) | France | $128.708B | 0.00 |
| Medtronic (MDT) | Ireland | $111.928B | 15.99 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.371B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.904B | 27.49 |
| Agilent Technologies (A) | United States | $33.258B | 22.04 |
| GE HealthCare Technologies (GEHC) | United States | $33.082B | 15.84 |
| Terumo (TRUMY) | Japan | $26.680B | 34.37 |
| Insulet (PODD) | United States | $21.438B | 84.69 |
| Koninklijke Philips (PHG) | Netherlands | $21.384B | 15.43 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.060B | 11.71 |
| Baxter (BAX) | United States | $15.713B | 11.81 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.872B | 0.00 |
| Demant (WILYY) | Denmark | $9.377B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.175B | 21.94 |
| Lantheus Holdings (LNTH) | United States | $5.385B | 13.58 |
| Prestige Consumer Healthcare (PBH) | United States | $4.149B | 18.47 |
| Perrigo (PRGO) | Ireland | $3.664B | 9.30 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.367B | 15.31 |
| ICU Medical (ICUI) | United States | $3.250B | 24.18 |
| Envista Holdings (NVST) | United States | $3.127B | 26.73 |
| GN Store Nord (GNNDY) | Denmark | $2.263B | 19.32 |
| QuidelOrtho (QDEL) | United States | $1.954B | 13.59 |
| LeMaitre Vascular (LMAT) | United States | $1.833B | 41.46 |
| AtriCure (ATRC) | United States | $1.565B | 0.00 |
| Acuren (TIC) | United States | $1.357B | 0.00 |
| Neogen (NEOG) | United States | $1.200B | 15.67 |
| AdaptHealth (AHCO) | United States | $1.161B | 11.81 |
| Green Thumb Industries (GTBIF) | United States | $1.048B | 23.71 |
| BioLife Solutions (BLFS) | United States | $1.046B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.970B | 12.80 |
| Kestra Medical Technologies (KMTS) | United States | $0.904B | 0.00 |
| InMode (INMD) | Israel | $0.844B | 8.55 |
| Evolus (EOLS) | United States | $0.640B | 0.00 |
| CeriBell (CBLL) | United States | $0.624B | 0.00 |
| Owens & Minor (OMI) | United States | $0.602B | 5.08 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.542B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.538B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.524B | 0.00 |
| Valneva SE (VALN) | France | $0.510B | 0.00 |
| Surmodics (SRDX) | United States | $0.417B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.407B | 0.00 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.337B | 12.53 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.329B | 61.50 |
| Canopy Growth (CGC) | Canada | $0.272B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.263B | 22.50 |
| Sanara MedTech (SMTI) | United States | $0.256B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.254B | 0.00 |
| ZimVie (ZIMV) | United States | $0.253B | 11.63 |
| Cerus (CERS) | United States | $0.252B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.245B | 0.00 |
| Quanterix (QTRX) | United States | $0.235B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.221B | 0.00 |
| Biote (BTMD) | United States | $0.207B | 6.12 |
| Brainsway (BWAY) | Israel | $0.206B | 55.30 |
| Omeros (OMER) | United States | $0.199B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.196B | 0.00 |
| Organigram Global (OGI) | Canada | $0.187B | 0.00 |
| High Tide (HITI) | Canada | $0.185B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.179B | 14.57 |
| Verano Holdings (VRNOF) | United States | $0.174B | 0.00 |
| Exagen (XGN) | United States | $0.152B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.140B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.131B | 15.33 |
| Jin Medical (ZJYL) | China | $0.107B | 0.00 |
| MacroGenics (MGNX) | United States | $0.096B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.37 |
| Veru (VERU) | United States | $0.090B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.087B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Agape ATP (ATPC) | $0.084B | 0.00 | |
| TerrAscend (TSNDF) | Canada | $0.075B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Apyx Medical (APYX) | United States | $0.066B | 0.00 |
| Zynex (ZYXI) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 48.64 |
| United-Guardian (UG) | United States | $0.037B | 13.19 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.019B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| Safety Shot (SHOT) | United States | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| INLIF (INLF) | $0.012B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Senestech (SNES) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |